Expertise in
5
conditions

Matt Lechner

43-45 Foley Street, W1W 7TS, 
London, ENG, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
43-45 Foley Street, W1W 7TS, 
London, ENG, GB 

Overview

Matt Lechner practices practicing medicine in London, United Kingdom.

Mr. Lechner is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Anosmia, Olfactory Neuroblastoma, Sinus Cancer, Myringotomy, and Septoplasty.

He is actively involved in clinical research, co-authoring 125 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

43-45 Foley Street, W1W 7TS, London, ENG, United Kingdom
Other Locations
Queen Square, London, ENG, United Kingdom
Grays Inn Road, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective, Randomized, Double-blinded, Placebo-controlled, Cross-over Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) Towards the Ipsilateral Pterygopalatine Fossa for the Treatment of Craniofacial Pain
Prospective, Randomized, Double-blinded, Placebo-controlled, Cross-over Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) Towards the Ipsilateral Pterygopalatine Fossa for the Treatment of Craniofacial Pain
Enrollment Status: Recruiting
Publish Date: April 27, 2026
Intervention Type: Drug
Study Drug: Exparel
Study Phase: Phase 2

125 Total Publications

COPANOS: use of gabapentin in the management of post-viral parosmia - a double-blind, randomised, placebo-controlled, multi-site trial - study protocol.
COPANOS: use of gabapentin in the management of post-viral parosmia - a double-blind, randomised, placebo-controlled, multi-site trial - study protocol.
Journal: BMJ open
Published: July 23, 2026

Frequently Asked Questions about Matt Lechner

Is Matt Lechner a top-rated expert for Anosmia?

MediFind is an objective health platform that identifies experts based on real-world data. Matt Lechner is classified as an Distinguished expert for Anosmia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Matt Lechner participate in research or clinical trials?

Yes. Matt Lechner has published 125 articles and abstracts on conditions like Anosmia. You can view a list of Matt Lechner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lechner's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile